在KRAS/LKB1突变肺癌细胞中维持胺池和DNA合成
Jiyeon Kim1, Zeping Hu1, Ling Cai1
1Children's Medical Center Research Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Nature
|May 25, 2017
概括
具有KRAS和LKB1突变的侵袭性非小细胞肺癌依赖于碳酸盐合成酶-1 (CPS1) 来合成胺. 通过消耗pyrimidines,抑制CPS1会导致细胞死亡,从而成为潜在的治疗点.
科学领域:
- 癌症学
- 癌症新陈代谢
- 分子生物学
背景情况:
- 包括KRAS突变在内的瘤信号驱动了对癌症发病和进展至关重要的代谢重编程.
- 非小细胞肺癌 (NSCLC) 经常含有KRAS和瘤抑制剂STK11 (编码LKB1) 的突变,同时存在与侵袭性疾病相关的突变 (KL).
- 代谢失调,特别是在处理方面,是KL NSCLC的标志.
研究的目的:
- 研究具有KRAS和LKB1突变的侵袭性非小细胞肺癌 (NSCLC) 的代谢变化.
- 阐明碳酸盐合成酶-1 (CPS1) 在KL NSCLC细胞的代谢中的作用及其对瘤生长的影响.
- 确定与KL NSCLC中观察到的代谢重编程相关的潜在治疗漏洞.
主要方法:
- 对人类KL细胞和瘤进行比较的代谢分析,以确定乱的代谢途径.
- 研究碳酸盐合成酶-1 (CPS1) 表达及其通过LKB1/AMPK信号的调节.
- 功能性研究涉及KL细胞中CPS1沉默和外源性胺补充剂,以评估细胞死亡,瘤生长和DNA损伤.
主要成果:
- KL细胞和瘤表现出独特的代谢特征,其特征是改变处理,包括carbamoyl phosphate synthetase-1 (CPS1) 的表达.
- LKB1通过AMPK抑制CPS1转录;CPS1表达与人类NSCLC中的LKB1水平相反相关.
- 在KL细胞中抑制CPS1导致细胞死亡,而不是氨毒性,并通过破坏DNA合成和导致DNA损伤来减少瘤生长.
结论:
- 这种KL瘤基因型在侵袭性NSCLC中产生了代谢脆弱性,依赖于非传统的-胺代谢途径.
- 在KL NSCLC中,CPS1在快速细胞增殖中发挥着关键作用.
- 针对CPS1或胺合成途径代表了对这种侵袭性NSCLC的有希望的治疗策略.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K


